The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases
Orit Kaidar‐Person(Dana-Farber Cancer Institute), Timothy M. Zagar(University of North Carolina at Chapel Hill), Jayne Camporeale(University of North Carolina at Chapel Hill), Allison M. Deal(Memorial Sloan Kettering Cancer Center), Lawrence B. Marks(University of North Carolina at Chapel Hill), Juanita Ramirez(University of North Carolina at Chapel Hill), Matthew G. Ewend, Carey K. Anders(Duke University), Julia M. Benbow(University of North Carolina at Chapel Hill), Elizabeth Claire Dees(University of North Carolina at Chapel Hill)
Cited by 8
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k